A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC)

Clinical trial NCT03595124 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03595124
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma Stage III Renal Cell Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8 TFE3-Rearranged Renal Cell Carcinoma Unresectable Renal Cell Carcinoma

Start date: 2019-01-08
Primary completion: 2024-09-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.